Tempo Therapeutics

Tempo Therapeutics is a clinical-stage company focused on regenerative medicine, utilizing its patented Microporous-Annealed-Particle (MAP) technology to develop synthetic biomaterials for surgical reconstruction and therapeutic applications. Their MAP technology creates hyper-porous scaffolds promoting tissue ingrowth and integration, evading typical scar formation and stimulating a regenerative immune response. This leads to the development of stronger, healthier native tissue.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $12M

Date: 19-Mar-2024

Investors: Galaxy-Sirius Partners, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), YK Bioventures, AJAX Captial Partners

Markets: Regenerative Medicine, Tissue Engineering, Biotechnology Research, Health Care, Medical, Therapeutics

HQ: San Diego, California, United States

Founded: 2014

Website: https://www.tempothera.com/

LinkedIn: https://www.linkedin.com/company/tempo-therapeutics

Twitter:

Instagram: